Beyond Large Models! Weiming Penguin Unveils a Major Upgrade to Its AI-Native Solutions, Building New Quality Productive Forces for Pharmaceutical Companies
Article images may contain Chinese text.
Two days of exchanging ideas, and an industry gathering full of insights! A delegation led by Weiming Penguin Co-founder & President Teresa joined industry colleagues to explore new paths for pharmaceutical digital transformation. Held on March 26–27, 2026, the CIAPH 14th Pharmaceutical and Healthcare Industry Digital and Intelligent Transformation Summit Forum concluded successfully at the Chateau Star River Pudong Shanghai.

At this exhibition, Weiming Penguin unveiled the 2026 upgrade to its AI-native digital and intelligent transformation solutions. Centered on “AI-native digital and intelligent transformation + real-world implementation,” the upgrade deeply integrates technological innovation with practical services, winning recognition across the venue and showing more pharmaceutical companies new possibilities for digital and intelligent transformation.

Built on the intelligent foundation of the independently developed StarPlex pharmaceutical AI solution, the upgraded solutions are closely tailored to pharmaceutical compliance requirements. They cover the full range of scenarios, including data integration, data governance, connecting patient case records, and decision support. By breaking down system barriers, they turn “dormant data assets” into “new quality productive forces” that drive business growth, helping pharmaceutical companies move from “viewing figures in data” to “intelligent anticipation and action.”
At this exhibition, Weiming Penguin also appeared as an “enterprise lobster-raising expert,” introducing its innovative “enterprise lobster-raising service.”

The successful conclusion of this CIAPH Summit Forum was another compelling showcase of Weiming Penguin’s AI-native digital and intelligent transformation capabilities. It also vividly reflected the pharmaceutical industry’s urgent need for efficient, compliant, and deployable digital and intelligent transformation solutions.

Weiming Penguin Co-founder & President Teresa also discussed the industry’s future with experts, exploring new paths for technology implementation and industry development around the key issues in pharmaceutical digital and intelligent transformation.
Looking ahead, Weiming Penguin will remain committed to its core mission of “Connecting Health,” using the StarPlex pharmaceutical AI solution as its central engine to deepen applications across pharmaceutical industry scenarios. We will continue to iterate our AI-native digital and intelligent transformation solutions and innovative service system, ensuring that technology truly fits business scenarios while retaining a human touch. We will help more pharmaceutical companies overcome transformation challenges, unlock data value, and strengthen their core competitiveness, working together to build a new digital and intelligent future for the healthcare industry!
Weiming Penguin—Your AI-Native Digital and Intelligent Transformation Partner, Joining the Pharmaceutical Industry on a New Intelligent Journey!

